Misty Dawn Shields

Misty Dawn Shields: Excellent discussion at TexasLung25 on fusions in NSCLC

Misty Dawn Shields, Assistant Professor at Indiana University School of Medicine, shared a post on X:

“Excellent discussion at TexasLung25 on fusions in NSCLC (ALK, ROS1, RET, NTRK, NRG1).

Important points to guide tx:
  • Toxicities (ID, management, risks)
  • CNS efficacy & penetration
  •  Acquired resistance mechanisms

NSCLC

More posts featuring Misty Dawn Shields.

cancer Lung cancer Misty Dawn Shields NSCLC OncoDaily Oncology TexasLung25